Cite
HARVARD Citation
Versteijne, E. et al. (2022). Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial. Journal of clinical oncology. 40 (11), pp. 1220-1230. [Online].